miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4
Hits:
Affiliation of Author(s):32000
Journal:INTERNATIONAL IMMUNOPHARMACOLOGY
ISSN No.:1567-5769
Translation or Not:no